Research from UPMC Hillman Cancer Center is challenging the prevailing hypothesis for how donor stem cell grafts cause graft-versus-host disease and offers an alternative model that could guide development of novel therapies.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe